Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid

Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid

Background and Purpose: Growth hormone (GH) has been frequently used to control the aging process in healthy individuals, probably due to its slowing effect on senescence-associated degeneration. Mitochondrial dysfunction is related to the aging process, and one of the chemical models of Huntington’...

Full description

Bibliographic Details
Main Authors:	Jung-Eun Park, Soon-Tae Lee, Woo-Seok Im, Manho Kim
Format:	Article
Language:	English
Published:	Korean Movement Disorders Society 2013-10-01
Series:	Journal of Movement Disorders
Subjects:	Growth hormone 3-nitropropionic acid Huntington’s disease Mitochondria
Online Access:	http://e-jmd.org/upload/jmd-6-2-28-2.pdf

Similar Items

Minocycline in phenotypic models of Huntington's disease
by: Kadiombo Bantubungi, et al.
Published: (2005-02-01)

Plastic and behavioral abnormalities in experimental Huntington's disease: A crucial role for cholinergic interneurons
by: Barbara Picconi, et al.
Published: (2006-04-01)

Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism
by: Jai Malik, et al.
Published: (2017-01-01)

Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease
by: Shilpa Ramaswamy, et al.
Published: (2007-05-01)

3-Nitropropionic Acid as a Tool to Study the Mechanisms Involved in Huntington’s Disease: Past, Present and Future
by: Abel Santamaría, et al.
Published: (2010-02-01)

Striatal and Cortical Neurochemical Changes Induced by Chronic Metabolic Compromise in the 3-Nitropropionic Model of Huntington's Disease
by: David Blum, et al.
Published: (2002-08-01)

Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington's disease in rats
by: Navneet Kaur, et al.
Published: (2015-01-01)

Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease
by: Maddalena Napolitano, et al.
Published: (2004-03-01)

Worsening of Huntington disease phenotype in CB1 receptor knockout mice
by: Stéphane Mievis, et al.
Published: (2011-06-01)

Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF
by: Elena Puerta, et al.
Published: (2010-05-01)

Efeito protetor do extrato aquoso de luehea divaricata contra os danos oxidativos e comportamentais induzidos pelo ácido 3-nitropropiônico em ratos
by: Courtes, Aline Alves
Published: (2016)

Experimental basis for the putative role of GluR6/kainate glutamate receptor subunit in Huntington's disease natural history
by: Elsa Diguet, et al.
Published: (2004-04-01)

Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms
by: Marie-Christine Galas, et al.
Published: (2004-02-01)

Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease
by: Jae K Ryu, et al.
Published: (2004-06-01)

Erythropoietin and sonic hedgehog mediate the neuroprotective effects of brain-derived neurotrophic factor against mitochondrial inhibition
by: Chia-Lin Wu, et al.
Published: (2010-10-01)

Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin
by: Julieta Saba, et al.
Published: (2020-10-01)

BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons
by: Sandra Almeida, et al.
Published: (2009-09-01)

Mitochondrial dynamics and quality control in Huntington's disease
by: Pedro Guedes-Dias, et al.
Published: (2016-06-01)

Efeitos do ácido 3-nitropropiônico (3-NP) na inervação extrínseca do coração de camundongos - modelo experimental para a doença de Huntington
by: Amanda Lopez Moreira
Published: (2017)

Efeitos do ácido 3-nitropropiônico (3-NP) na inervação extrínseca do coração de camundongos - modelo experimental para a doença de Huntington
by: Moreira, Amanda Lopez
Published: (2017)

A Case of Juvenile Huntington Disease in a 6-Year-Old Boy
by: Jun-Sang Sunwoo, et al.
Published: (2010-10-01)

Metabolic and hormonal signatures in pre-manifest and manifest Huntington’s disease patients
by: Rui eWang, et al.
Published: (2014-06-01)

Cell Therapy Strategies vs. Paracrine Effect in Huntington’s Disease
by: Wooseok Im, et al.
Published: (2014-04-01)

FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures
by: Sandra Almeida, et al.
Published: (2004-12-01)

Cardiac dysfunction in the R6/2 mouse model of Huntington’s disease
by: Michael J. Mihm, et al.
Published: (2007-02-01)

The NMDA receptor subunit GluN3A protects against 3-nitroproprionic-induced striatal lesions via inhibition of calpain activation
by: Rebeca Martínez-Turrillas, et al.
Published: (2012-12-01)

A Rationale for Hypoxic and Chemical Conditioning in Huntington’s Disease
by: Johannes Burtscher, et al.
Published: (2021-01-01)

Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications
by: Bindu D. Paul, et al.
Published: (2019-03-01)

Normal platelet mitochondrial complex I activity in Huntington’s Disease
by: William J. Powers, et al.
Published: (2007-07-01)

Oxidative metabolism and mitochondrial calcium handling in mouse models of Huntington's Disease
by: Hamilton, James M.
Published: (2017)

Exosomes as a potential messenger unit during heterochronic parabiosis for amelioration of Huntington's disease
by: Mijung Lee, et al.
Published: (2021-07-01)

Regulation of neuronal calcium homeostasis in Huntington's
by: Pellman, Jessica J.
Published: (2016)

High stress hormone levels accelerate the onset of memory deficits in male Huntington's disease mice
by: Christina Mo, et al.
Published: (2014-09-01)

Mitochondrial Respiration Changes in R6/2 Huntington’s Disease Model Mice during Aging in a Brain Region Specific Manner
by: Johannes Burtscher, et al.
Published: (2020-07-01)

Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease
by: Hua Zhang, et al.
Published: (2008-07-01)

Exosome-Based Delivery of miR-124 in a Huntington’s Disease Model
by: Soon-Tae Lee, et al.
Published: (2017-01-01)

Mitochondrial fission in Huntington's disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca2+ efflux and Reactive Oxygen Species (ROS) homeostasis
by: Marta Cherubini, et al.
Published: (2020-03-01)

The association of VDAC with cell viability of PC12 model of Huntington’s disease
by: Andonis Karachitos, et al.
Published: (2016-11-01)

Efecto del 3-nitropropionato sobre el metabolismo del lactato y del acetato en neuronas y astrocitos crecidos in vitro en concentraciones perinatales
by: Jairo Alfonso Tovar- Franco, et al.
Published: (2009-04-01)

Repeated immune activation with low-dose lipopolysaccharide attenuates the severity of Huntington's disease in R6/2 transgenic mice
by: Sung Won Lee, et al.
Published: (2018-07-01)